Previous Close | 22.95 |
1-Year Change | -25.46% |
6-Months Change | -11.15% |
3-Months Change | -19.81% |
Moving Avg (50d) | 30.616 |
Moving Avg (200d) | 28.699 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 2.92B |
Beta (3-Years) | 1.87 |
Revenue Growth (ttm) | 8.55% |
Net Profit Margin (ttm) | -1.17% |
Return On Assets (ttm) | -0.45% |
EPS (ttm) | -0.26 |
PE Ratio (ttm) | -88.27 |
Dividend Yield | % |
Asset Description: | Surgery Partners, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-10-23 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
23.47 | 24.161 | 24.621 | 25.311 | 26.462 | 27.612 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.